The accepted paper, titled "Evaluation of Urcosimod in Neuropathic Corneal Pain: Efficacy and Safety Results from a Proof-of-Concept Pilot Phase 2 Study", will be presented in the Ocular Surface ...
Key highlights from the Type C FDA meeting include: FDA confirms the approach that the proposed primary endpoint of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results